UNSPSC 51152033: Inaperisone

This classification denotes a muscle relaxant with the molecular formula C16H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0QAC3P785O, chemically known as 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-pyrrolidinyl)-, but generally known as inaperisone, which bears US NIH Compound Identifier 65860. European Medicines Agency schedules Inaperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08162MIG.

UNSPSC 51152033 Inaperisone is a Commodity code that does not align with the state and local procurement activity currently tagged to it. The recent solicitation in the dataset—Seminole County, Florida's IFB60459723LAS for Naloxone and drug deactivation systems—involves pharmaceutical products and harm-reduction equipment unrelated to inaperisone, a muscle relaxant. State and local governments do not appear to be actively procuring inaperisone through the public contracting channels captured in this dataset.

The single recent opportunity tagged to this code reflects a different scope entirely. Seminole County released an IFB on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2026, for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The mismatch between the UNSPSC code label and the actual procurement suggests either a data-entry error in the source system or that this code is not in active use for relevant state and local buying. No additional opportunities under this code appear in the dataset.